Addus HomeCare (NASDAQ:ADUS – Free Report) had its price target cut by Barclays from $112.00 to $102.00 in a report issued on Wednesday,Benzinga reports. They currently have an underweight rating on the stock.
A number of other research firms also recently commented on ADUS. Royal Bank Of Canada restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Wednesday, February 25th. Stephens decreased their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Truist Financial set a $135.00 price target on Addus HomeCare and gave the company a “buy” rating in a research note on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $133.22.
View Our Latest Report on Addus HomeCare
Addus HomeCare Price Performance
Insider Activity at Addus HomeCare
In related news, CEO R Dirk Allison sold 4,988 shares of the stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $533,616.24. Following the completion of the sale, the chief executive officer directly owned 185,514 shares of the company’s stock, valued at $19,846,287.72. This represents a 2.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Darby Anderson sold 733 shares of the firm’s stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $78,416.34. Following the sale, the executive vice president owned 46,642 shares of the company’s stock, valued at $4,989,761.16. The trade was a 1.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 16,610 shares of company stock worth $1,768,970. Company insiders own 4.50% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Royal Bank of Canada boosted its stake in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after acquiring an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Addus HomeCare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after purchasing an additional 2,952 shares during the period. Jane Street Group LLC raised its position in shares of Addus HomeCare by 387.6% during the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares during the period. Finally, Intech Investment Management LLC lifted its holdings in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after purchasing an additional 4,439 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Further Reading
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
